Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Julie Le Naour, Laurence Zitvogel, Lorenzo Galluzzi, Erika Vacchelli & Guido Kroemer. (2020) Trial watch: STING agonists in cancer therapy. OncoImmunology 9:1.
Read now
Read now
Wen-Ting Zhu, Sheng-Yao Liu, Lei Wu, Hua-Li Xu, Jun Wang, Guo-Xin Ni & Qing-Bing Zeng. (2017) Delivery of curcumin by directed self-assembled micelles enhances therapeutic treatment of non-small-cell lung cancer. International Journal of Nanomedicine 12, pages 2621-2634.
Read now
Read now
N. Malecic & H. S. Young. (2016) Novel investigational vascular endothelial growth factor (VEGF) receptor antagonists for psoriasis. Expert Opinion on Investigational Drugs 25:4, pages 455-462.
Read now
Read now
Martin Reck & Anders Mellemgaard. (2015) Emerging treatments and combinations in the management of NSCLC: clinical potential of nintedanib. Biologics: Targets and Therapy 9, pages 47-56.
Read now
Read now
Erika Rijavec, Carlo Genova, Giulia Barletta, Federica Biello, Maria Giovanna Dal Bello, Simona Coco, Anna Truini, Irene Vanni, Angela Alama, Francesco Boccardo & Francesco Grossi. (2014) Efficacy of motesanib diphosphate in non-small-cell lung cancer. Expert Opinion on Pharmacotherapy 15:12, pages 1771-1780.
Read now
Read now
Zhen Lu, Maria T Baquero, Hailing Yang, Maojie Yang, Albert S Reger, Choel Kim, Douglas A Levine, Charlotte H Clarke, Warren S-L Liao & Robert C Bast Jr. (2014) DIRAS3 regulates the autophagosome initiation complex in dormant ovarian cancer cells. Autophagy 10:6, pages 1071-1092.
Read now
Read now
Xing-qi Li, Zhi-gang Ouyang, Sheng-hua Zhang, Hong Liu, Yue Shang, Yi Li & Yong-su Zhen. (2014) Synergistic inhibition of angiogenesis and glioma cell-induced angiogenesis by the combination of temozolomide and enediyne antibiotic lidamycin. Cancer Biology & Therapy 15:4, pages 398-408.
Read now
Read now
Anja K Weidemann, Ania A Crawshaw, Emily Byrne & Helen S Young. (2013) Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasis. Clinical, Cosmetic and Investigational Dermatology 6, pages 233-244.
Read now
Read now
Robert Roskoski$suffix/text()$suffix/text(). (2013) The preclinical profile of crizotinib for the treatment of non-small-cell lung cancer and other neoplastic disorders. Expert Opinion on Drug Discovery 8:9, pages 1165-1179.
Read now
Read now
Jianwei Zhang, Yan Huang, Xiaoling Li, Ying Guo, Yuanyuan Zhao, Cong Xue, Zhihuang Hu, Li Zhang & Hongyun Zhao. (2012) The impact of tumor size change after target therapy on survival: analysis of patients enrolled onto three clinical trials of advanced NSCLC from one institution. OncoTargets and Therapy 5, pages 349-355.
Read now
Read now
Jianjun Zhang, Kathryn A Gold & Edward Kim. (2012)
Sorafenib in non-small cell lung cancer. Expert Opinion on Investigational Drugs 21:9, pages 1417-1426.
Read now
Read now
Articles from other publishers (37)
Tatyana V. Korneenko, Nikolay B. Pestov, Ivan A. Nevzorov, Alexandra A. Daks, Kirill N. Trachuk, Olga N. Solopova & Nickolai A. Barlev. (2023) At the Crossroads of the cGAS-cGAMP-STING Pathway and the DNA Damage Response: Implications for Cancer Progression and Treatment. Pharmaceuticals 16:12, pages 1675.
Crossref
Crossref
Jianxin Li & Ting Han. (2023) Comprehensive analysis of the oncogenic roles of vascular endothelial growth factors and their receptors in stomach adenocarcinoma. Heliyon 9:7, pages e17687.
Crossref
Crossref
Zheng-Hong Chen, Yi-Li Zhang, Bin Yuan, Wen-Juan Chen, Guang-Yan Lei & Le Han. (2023) 125I seed implantation enhances arsenic trioxide-induced apoptosis and anti-angiogenesis in lung cancer xenograft mice. Clinical and Translational Oncology 25:7, pages 2127-2137.
Crossref
Crossref
Yu Feng, Le Tang, Hongyu Wang, Yutao Liu, Sheng Yang, Lin Lin, Xingsheng Hu & Yuankai Shi. (2022) Immune checkpoint inhibitors combined with angiogenic inhibitors in the treatment of locally advanced or metastatic lung adenocarcinoma patients. Cancer Immunology, Immunotherapy 72:2, pages 449-459.
Crossref
Crossref
Suman Rohilla, Mahaveer Singh, Sami I. Alzarea, Waleed Hassan Almalki, Fahad A. Al-Abbasi, Imran Kazmi, Obaid Afzal, Abdulmalik Saleh Alfawaz Altamimi, Sachin Kumar Singh, Dinesh Kumar Chellappan, Kamal Dua & Gaurav Gupta. (2023) Recent Developments and Challenges in Molecular-Targeted Therapy of Non-Small-Cell Lung Cancer. Journal of Environmental Pathology, Toxicology and Oncology 42:1, pages 27-50.
Crossref
Crossref
Adnin Ashrafi, Zakia Akter, Pouya Modareszadeh, Parsa Modareszadeh, Eranda Berisha, Parinaz Sadat Alemi, Maria del Carmen Chacon Castro, Alexander R. Deese & Li Zhang. (2022) Current Landscape of Therapeutic Resistance in Lung Cancer and Promising Strategies to Overcome Resistance. Cancers 14:19, pages 4562.
Crossref
Crossref
Denisa Baci, Elona Cekani, Andrea Imperatori, Domenico Ribatti & Lorenzo Mortara. (2022) Host-Related Factors as Targetable Drivers of Immunotherapy Response in Non-Small Cell Lung Cancer Patients. Frontiers in Immunology 13.
Crossref
Crossref
Baikun Li, Xingyu Dong, Jimin Zhu, Ting Zhu, Xiaoxiao Tao, Daiyin Peng & Qinglin Li. (2021) Crosstalk between H1975 tumor cells and platelets to induce the proliferation, migration and tube formation of vascular endothelial cells. Oncology Letters 22:3.
Crossref
Crossref
Mi Zhang, Haitian Quan, Li Fu, Yun Li, Haoyu Fu & Liguang Lou. (2021)
Third‐generation
EGFR
inhibitor
HS
‐10296 in combination with famitinib, a multi‐targeted tyrosine kinase inhibitor, exerts synergistic antitumor effects through enhanced inhibition of downstream signaling in
EGFR
‐mutant non‐small cell lung cancer cells
. Thoracic Cancer 12:8, pages 1210-1218.
Crossref
Crossref
Ying Chen, Qi Li, Qihang Li, Shuaishuai Xing, Yang Liu, Yijun Liu, Yao Chen, Wenyuan Liu, Feng Feng & Haopeng Sun. (2020) p62/SQSTM1, a Central but Unexploited Target: Advances in Its Physiological/Pathogenic Functions and Small Molecular Modulators. Journal of Medicinal Chemistry 63:18, pages 10135-10157.
Crossref
Crossref
Fen Wang, Julian Molina, Daniel Satele, Jun Yin, Vun-Sin Lim & Alex A. Adjei. (2018) A phase I study of the vascular endothelial growth factor inhibitor Vatalanib in combination with Pemetrexed disodium in patients with advanced solid tumors. Investigational New Drugs 37:4, pages 658-665.
Crossref
Crossref
Haoru Fan, Dengshuai Wei, Kun Zheng, Xuemei Qin, Leifu Yang, Yajuan Yang, Ye Duan, Yinsheng Xu & Liming Hu. (2019) Discovery of Dioxino[2,3-f]quinazoline derivative VEGFR-2 inhibitors exerting significant antipro-liferative activity in HUVECs and mice. European Journal of Medicinal Chemistry 175, pages 349-356.
Crossref
Crossref
Seung Hwan Moon, Jong-Mu Sun, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn & Joon Young Choi. (2019) Pretreatment Tumor 18F-FDG Uptake Improves Risk Stratification Beyond RECIST 1.1 in Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer. Clinical Nuclear Medicine 44:2, pages e60-e67.
Crossref
Crossref
Elaine Vickers. 2018. A Beginner's Guide to Targeted Cancer Treatments. A Beginner's Guide to Targeted Cancer Treatments
187
257
.
Ya-Wen Sun, Jian Xu, Jun Zhou & Wen-Juan Liu. (2017) Targeted drugs for systemic therapy of lung cancer with brain metastases. Oncotarget 9:4, pages 5459-5472.
Crossref
Crossref
Ewa Maj, Beata Filip-Psurska, Magdalena Milczarek, Mateusz Psurski, Andrzej Kutner & Joanna Wietrzyk. (2017) Vitamin�D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model. International Journal of Oncology.
Crossref
Crossref
Dinesh Kumar Chellappan, Jestin Chellian, Zhao Yin Ng, Yan Jinn Sim, Chiu Wei Theng, Joyce Ling, Mei Wong, Jia Hui Foo, Goh Jun Yang, Li Yu Hang, Saranyah Nathan, Yogendra Singh & Gaurav Gupta. (2017) The role of pazopanib on tumour angiogenesis and in the management of cancers: A review. Biomedicine & Pharmacotherapy 96, pages 768-781.
Crossref
Crossref
Adam R. Travis, Virginia A. Liau, Amanda C. Agrawal & David E. Cliffel. (2017) Small gold nanoparticles presenting linear and looped Cilengitide analogues as radiosensitizers of cells expressing ανβ3 integrin. Journal of Nanoparticle Research 19:11.
Crossref
Crossref
Meng-Hang Yang, Ke-Jie Chang, Jin-Cheng Zheng, Hai Huang, Guang-Yuan Sun, Xue-Wei Zhao, Bing Li & Qing-Yu Xiu. (2017) Anti-angiogenic effect of arsenic trioxide in lung cancer via inhibition of endothelial cell migration, proliferation and tube formation. Oncology Letters 14:3, pages 3103-3109.
Crossref
Crossref
Jun Wang, Jianpeng Chen, Yan Guo, Baocheng Wang & Huili Chu. (2017) Strategies targeting angiogenesis in advanced non-small cell lung cancer. Oncotarget 8:32, pages 53854-53872.
Crossref
Crossref
Ana Luísa Coelho, Mónica Patrícia Gomes, Raquel Jorge Catarino, Christian Rolfo, Agostinho Marques Lopes, Rui Manuel Medeiros & António Manuel Araújo. (2016) Angiogenesis in NSCLC: is vessel co-option the trunk that sustains the branches?. Oncotarget 8:24, pages 39795-39804.
Crossref
Crossref
Akiko Harada, Junji Uchino, Taishi Harada, Noriaki Nakagaki, Junko Hisasue, Masaki Fujita & Koichi Takayama. (2017) Vascular endothelial growth factor promoter-based conditionally replicative adenoviruses effectively suppress growth of malignant pleural mesothelioma. Cancer Science 108:1, pages 116-123.
Crossref
Crossref
Vivek Mittal, Tina El Rayes, Navneet Narula, Timothy E. McGraw, Nasser K Altorki & Mary Helen Barcellos-Hoff. 2016. Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management. Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management
75
110
.
Jiho Song, Jakyung Yoo, Ara Kwon, Doran Kim, Hong Khanh Nguyen, Bong-Yong Lee, Wonhee Suh & Kyung Hoon Min. (2015) Structure-Activity Relationship of Indole-Tethered Pyrimidine Derivatives that Concurrently Inhibit Epidermal Growth Factor Receptor and Other Angiokinases. PLOS ONE 10:9, pages e0138823.
Crossref
Crossref
SUSANNE GAHR, CHRISTIAN MAYR, TOBIAS KIESSLICH, ROMANA ILLIG, DANIEL NEUREITER, BEATE ALINGER, MARION GANSLMAYER, TILL WISSNIOWSKI, PIETRO DI FAZIO, ROBERTA MONTALBANO, JOACHIM H. FICKER, MATTHIAS OCKER & KARL QUINT. (2015) The pan-deacetylase inhibitor panobinostat affects angiogenesis in hepatocellular carcinoma models via modulation of CTGF expression. International Journal of Oncology 47:3, pages 963-970.
Crossref
Crossref
Ting Zhou, Lie Zheng, Zhihuang Hu, Yang Zhang, Wenfeng Fang, Yuanyuan Zhao, Jieying Ge, Hongyun Zhao & Li Zhang. (2015) The Effectiveness of RECIST on Survival in Patients with NSCLC Receiving Chemotherapy with or without Target Agents as First-Line Treatment. Scientific Reports 5:1.
Crossref
Crossref
Tina El Rayes, Raul Catena, Shahin Rafii, Nasser Altorki & Vivek Mittal. 2015. Inflammation and Lung Cancer. Inflammation and Lung Cancer
137
159
.
Y. Hu, M.-m. Hu, G.-l. Shi, Y. Han & B.-l. Li. (2014) Imbalance between vascular endothelial growth factor and endostatin correlates with the prognosis of operable non-small cell lung cancer. European Journal of Surgical Oncology (EJSO) 40:9, pages 1136-1142.
Crossref
Crossref
Gilda G. Hillman, Fulvio Lonardo, David J. Hoogstra, Joseph Rakowski, Christopher K. Yunker, Michael C. Joiner, Gregory Dyson, Shirish Gadgeel & Vinita Singh-Gupta. (2014) Axitinib Improves Radiotherapy in Murine Xenograft Lung Tumors. Translational Oncology 7:3, pages 400-409.
Crossref
Crossref
Tao Zhang, Ting-Ting Yu, Dong-Ming Zhang, Xiao-Ming Hou, Xiao-Jun Liu, Da Zhao & Li Shan. (2014) Vasohibin-1 expression detected by immunohistochemistry correlates with prognosis in non-small cell lung cancer. Medical Oncology 31:5.
Crossref
Crossref
S J An, Y S Huang, Z H Chen, J F Han, J J Yang, Q Zhou, Z Xie, Y Yang, H H Yan & Y L Wu. (2014) Lower Ras expression as an independent predictor of patient outcomes in lung cancer treated with bevacizumab plus chemotherapy. Cancer Gene Therapy 21:3, pages 110-114.
Crossref
Crossref
Martin W Huellner, Timothy D Collen, Philipp Gut, Ralph Winterhalder, Chantal Pauli, Joachim Diebold, Burkhardt Seifert, Klaus Strobel & Patrick Veit-Haibach. (2014) Multiparametric PET/CT-perfusion does not add significant additional information for initial staging in lung cancer compared with standard PET/CT. EJNMMI Research 4:1, pages 6.
Crossref
Crossref
Nora Bittner, Gyula Ostoros & Lajos Géczi. (2013) New Treatment Options for Lung Adenocarcinoma - in View of Molecular Background. Pathology & Oncology Research 20:1, pages 11-25.
Crossref
Crossref
Sharad S. Singhal, James Figarola, Jyotsana Singhal, Lokesh Nagaprashantha, David Berz, Samuel Rahbar & Sanjay Awasthi. (2013) Novel compound 1,3-bis (3,5-dichlorophenyl) urea inhibits lung cancer progression. Biochemical Pharmacology 86:12, pages 1664-1672.
Crossref
Crossref
Frances A. ShepherdPaul A. BunnJr.Jr. & Luis Paz-Ares. (2013) Lung Cancer in 2013: State of the Art Therapy for Metastatic Disease. American Society of Clinical Oncology Educational Book:33, pages 339-346.
Crossref
Crossref
JIA-YING XU, QING-HUI MENG, YU CHONG, YANG JIAO, LIN ZHAO, ELIOT M. ROSEN & SAIJUN FAN. (2013) Sanguinarine is a novel VEGF inhibitor involved in the suppression of angiogenesis and cell migration. Molecular and Clinical Oncology 1:2, pages 331-336.
Crossref
Crossref
Paul J. Davis, Faith B. Davis, Hung-Yun Lin, Mary K. Luidens & Shaker A. Mousa. 2013. Angiogenesis Modulations in Health and Disease. Angiogenesis Modulations in Health and Disease
29
46
.